Nocardial infection in a renal transplant recipient on tacrolimus and mycophenolate mofetil

Clin Nephrol. 1999 Jul;52(1):44-6.

Abstract

Infection with Nocardia spp. is an uncommon but important cause of morbidity and mortality in organ transplant recipients. Cotrimoxazole prophylaxis against urinary tract infection and Pneumocystis carinii pneumonia in these patients usually prevents nocardial infection also. We report the case of a patient on tacrolimus and mycophenolate mofetil who developed drug-induced diabetes mellitus followed by nocardial brain infection. This infection occurred despite conventional cotrimoxazole prophylaxis. Physicians should be aware that newer, more potent and more diabetogenic immunosuppressive regimens may increase the risk of opportunistic infections such as nocardiosis, even in the presence of "adequate" antimicrobial preventive measures.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Brain Abscess / drug therapy
  • Brain Abscess / etiology*
  • Brain Abscess / pathology
  • Diabetes Mellitus / chemically induced
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Kidney Transplantation*
  • Male
  • Mycophenolic Acid / adverse effects
  • Mycophenolic Acid / analogs & derivatives*
  • Nocardia Infections / drug therapy
  • Nocardia Infections / etiology*
  • Nocardia Infections / pathology
  • Nocardia asteroides* / isolation & purification
  • Opportunistic Infections / prevention & control
  • Tacrolimus / adverse effects*
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Immunosuppressive Agents
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Mycophenolic Acid
  • Tacrolimus